Virax Biolabs (VRAX) Equity Average (2022 - 2023)
Virax Biolabs (VRAX) has 2 years of Equity Average data on record, last reported at $3.9 million in Q1 2023.
- For Q1 2023, Equity Average rose 479.95% year-over-year to $3.9 million; the TTM value through Mar 2023 reached $3.9 million, up 479.95%, while the annual FY2023 figure was $3.9 million, 479.95% up from the prior year.
- Equity Average reached $3.9 million in Q1 2023 per VRAX's latest filing, up from -$1.0 million in the prior quarter.
- Across five years, Equity Average topped out at $3.9 million in Q1 2023 and bottomed at -$1.0 million in Q1 2022.